loader image
Saturday, December 20, 2025
89 F
McAllen
- Advertisement -

Telemedicine ‘Hugely Beneficial’ for Health Care

Translate to Spanish or other 102 languages!

Telemedicine and virtual appointments have become more popular in routine health and wellness since the COVID-19 pandemic began. Image for illustration purposes
Telemedicine and virtual appointments have become more popular in routine health and wellness since the COVID-19 pandemic began. Image for illustration purposes

Mega Doctor News

- Advertisement -

By California State University, Fullerton

Telemedicine and virtual appointments have become more popular in routine health and wellness since the COVID-19 pandemic began.

Cal State Fullerton assistant professor of management David Cho co-authored a study examining the costs and benefits of these services. He notes that the benefits of telemedicine include shortened skilled-nursing facility stays and the potential for follow-up monitoring. It can also free up nursing beds and services, as well as reduce patients’ risk of being exposed to additional ailments.

- Advertisement -

Published in the journal Omega, the study reviewed patient telemedicine question response services typically offered by home health providers along with traditional home health therapy and nursing services.

These services have patients use smartphone apps or other digital monitoring features to answer questions related to medicine dosage, minor health ailments and dietary restrictions.

Cho said: “Our results show the benefits of telemedicine outweigh its operating costs in almost any scenario. Improvements in patient outcomes benefit not only the patients but can also be hugely beneficial for the entire healthcare system as well.”

“Telemedicine can identify patient concerns before they escalate into more serious issues, such as readmissions. These services are even more beneficial to those recently discharged.”

- Advertisement -

Read more at CSUF Business News.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -
×